About Eupraxia Pharmaceuticals Inc. Eupraxia is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release products that have the potential to address ...

Researchers have developed an innovative new method for identifying biomarkers in wastewater using origami-paper sensors, enabling the tracking of infectious diseases using the camera in a mobile ...

ComingSoon is excited to the exclusive The Activated Man posters for the upcoming horror thriller movie, The film will arrive ...

Multimedia projects aren’t a nice-to-have reward once the “real” learning is done. They’re a rigorous learning model that has ...

PictorLabs has completed a $30m Series B funding round to accelerate its AI-powered virtual staining technology. This ...

Larimar will present three posters during the conference, one of which will also be presented as an oral presentation. The poster presentations are as follows: Oral presentation by Dr. Russell Clayton ...

Abbisko Therapeutics (HKEX: 02256) is excited to announce the receipt of the ESMO 2024 Best Poster Award on September 16, 2024. The award was received for the presentation titled "Updated Safety and ...

Manuscript Types: Manuscripts must be formatted to match one of the following article types: Original Research, Systematic Reviews, Methods, Review, Mini Review, Perspective, Data Report, Brief ...

Kyverna Therapeutics, Inc. (Kyverna), a patient-centered, clinical-stage biopharmaceutical company focused on developing cell ...

Biomaterials are revolutionizing organoid development by offering tunable platforms that provide instructive cues, which enhance cell fate transitions, tissue-level functions and reproducibility ...